Analyst Update: Mobileye NV, Fitbit Inc, and Tenet Healthcare Corp

Analysts revised their ratings and price targets on Mobileye NV (NYSE:MBLY), Fitbit Inc (NYSE:FIT), and Tenet Healthcare Corp (NYSE:THC)

by Karee Venema

Published on Apr 13, 2016 at 3:07 PM
Updated on Jun 24, 2020 at 10:16 AM

Analysts are weighing in on tech stocks Mobileye NV (NYSE:MBLY) and Fitbit Inc (NYSE:FIT), as well as healthcare services firm Tenet Healthcare Corp (NYSE:THC). Here's a quick roundup of today's brokerage notes on MBLY, FIT, and THC.

  • MBLY has been soaring since hitting a record low of $23.57 on Feb. 9 -- up 69.2% -- thanks in part to rumors of a potential Tesla Motors Inc (NASDAQ:TSLA) partnership. Today, in fact, shares of MBLY are 2.4% higher at $39.87, despite a price-target cut to $11 at Citron Research, which called MBLY "the most outrageously overpriced, overhyped semiconductor stock ever." Option traders, meanwhile, have shown a distinct preference for puts over calls on Mobileye NV. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), MBLY's 10-day put/call volume ratio of 3.31 sits in the 98th annual percentile.

  • Raymond James gave its two cents on FIT, saying the "wearable market continues to show signs of healthy growth" -- an outlook that is also helping to lift GoPro Inc (NASDAQ:GPRO) today -- and maintaining its "outperform" rating. Along similar lines, Citigroup upped its per-share earnings and revenue estimates for Fitbit, while Pacific Crest bumped its first- and second-quarter unit sales forecasts for the company's Blaze fitness watch. Against this backdrop, shares of FIT are up 12.7% at $17.07, and on track for their best daily close since Jan. 25. These aren't the only analysts to wax optimistic on Fitbit Inc this week, though, and should the shares extend this positive price action, there's plenty of room for upgrades. In fact, 10 out of 21 brokerages maintain a lukewarm "hold" rating on FIT.

  • Susquehanna boosted its rating on THC to "positive" from "neutral," and lifted its price target to $38 from $23, citing increased confidence in management. This upbeat outlook has sent THC soaring 8.4% to $31.48 -- and back into the black on a year-to-date basis. Options traders, meanwhile, have kept the faith on THC, per the stock's 10-day ISE/CBOE/PHLX call/put volume ratio of 11.82 -- in the 96th annual percentile. Additionally, Tenet Healthcare Corp's Schaeffer's put/call open interest ratio (SOIR) of 0.37 sits lower than 93% of all comparable readings taken in the past year.
For other stocks in analysts' crosshairs, read Analyst Upgrades: Activision Blizzard, Inc., Dunkin Brands Group Inc, and ArcelorMittal SA and Analyst Downgrades: Alibaba Group Holding Ltd, Clovis Oncology Inc, and Sprint Corp.

A Schaeffer's 39th Anniversary Exclusive!

8 Top Stock Picks for 2020

Access your FREE insider report before it's too late!


  
 
 

Partnercenter